S100 proteins have significant clinical implications. They are often used as biomarkers for various diseases, including cancer. For example, S100B is frequently elevated in patients with malignant melanoma and can be used to monitor disease progression or response to therapy. Additionally, elevated levels of S100B in the blood can indicate brain damage, making it useful in the diagnosis of traumatic brain injury.
